2019
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody
Von Moos R, Costa L, Gonzalez-Suarez E, Terpos E, Niepel D, Body JJ
Journal: Cancer Treatment Reviews
Volume: 76
Année: Juin 2019
Pages: 57-67
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
Marino S, de Ridder D, Bishop RT, Renema N, Ponzetti M, Sophocleous A, Capulli M, Aljeffery A, Carrasco G, Gens MD, Khogeer A, Ralston SH, Gertsch J, Lamoureux F, Heymann D, Rucci N, Idris AI
Journal: EBioMedicine
Volume: 44
Année: Juin 2019
Pages: 452-466
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, Holzer G, Kendler D, Napoli N, Pierroz DD, Rizzoli R, Brandi ML
Journal: Annals of Oncology
Volume: 30, Issue 6
Année: Juin 2019
Pages: 908-920
Radionuclide imaging and therapy of bone metastases in the era of targeted therapy
Van den Wyngaert T, Paycha F
Journal: Journal of Nuclear Medicine and Molecular Imaging
Volume: 63, Issue 2
Année: Juin 2019
Pages: 95
Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI
Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE
Journal: Diagnostic and Interventional Imaging
Volume: 100, Issue 5
Année: Mai 2019
Pages: 295-302
Effets osseux des traitements de bisphosphonates et dénosumab en cas de cancer du sein ou de la prostate [Bone effects of bisphosphonates and denosumab treatments in breast or prostate cancer]
Biver E
Journal: Revue Médicale Suisse
Volume: 15
Année: Avril 2019
Pages: 824-830
https://www.revmed.ch/RMS/2019/RMS-N-647/Effets-osseux-des-traitements-de-bisph…
Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management
Confavreux CB, Pialat JB, Bellière A, Brevet M, Decroisette C, Tescaru A, Wegrzyn J, Barrey C, Mornex F, Souquet PJ, Girard N
Journal: Joint Bone Spine
Volume: 86, Issue 2
Année: Mars 2019
Pages: 185-194
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E.
Journal: Oncogene
Volume: 38, Issue 7
Année: Novembre 2019
Pages: 950-964
Intracardiac cement embolism during percutaneous vertebroplasty: incidence, risk factors and clinical management
Fadili Hassani S, Cormier E, Shotar E, Drir M, Spano JP, Morardet L, Collet JP, Chiras J, Clarençon F.
Journal: European Radiology
Volume: 29, Issue 2
Année: Février 2019
Pages: 663-673
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y
Journal: Journal of Bone Oncology
Volume: 14
Année: Février 2019
Pages:100212